Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

SSKN Stock Forecast, Price Targets, Chart, Dividends & Analysis

Strata Skin Sciences Inc. logo

Strata Skin Sciences Inc.

Sector: Healthcare   

Industry: Medical Instruments & Supplies

3.00
 
USD
  
0.01
  
(0.33%)
Previous close: 2.99  Open: 2.97  Bid: 2.9  Ask: 3.15
52 week range    
2.51   
   6.96
Mkt Cap: 12 M  Avg Vol (90 Days): 11,545
Peers   
PAVM / 
PECN / 
PEYE / 
Last updated: Thursday 5th December 2024

Stock Rankings

60
Value
36
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

PACB

1 B-12.08

PAVM

0 B01.1

PECN

PEYE

Financials

SSKN Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AcquiredInProcessRnDIncome3 M-193000.0
Amortization of intangibles-2 M-2 M-2 M-2 M9 M9 M9 M7 M
Basic EPS from continuing operations-0.13-0.16-0.31
Basic EPS total-1.55-3.26-0.15-0.11-0.13-0.08-0.16-0.31
Basic weighted shares outstanding1 M2 M2 M3 M20 M32 M34 M34 M35 M35 M
CommissionExpenses3 M
Cost of sales-5 M-14 M-13 M-13 M-13 M-11 M9 M24 M14 M15 M
Depreciation-2 M-3 M-5 M-4 M-4 M-3 M2 M4 M5 M6 M
Depreciation unreconciled2 M-6 M-5 M
DepreciationAndAmortization2 M-3 M-5 M-6 M-5 M-3 M2 M4 M5 M6 M
Diluted EPS total-15.15-16.35-3.75-3.26-0.15-0.11-0.13-0.08-0.16-0.31
Diluted normalized net income/share-0.13-0.16-0.31
Diluted weighted shares outstanding1 M3 M2 M3 M20 M32 M34 M34 M35 M35 M
Earnings from equity interest-3 M
EarningsFromEquityInterestNetOfTax-3 M
GainOnSaleOfPPE16000.0-25 M-124000.0-407000.0
GeneralAndAdministrativeExpense8 M10 M8 M8 M9 M10 M8 M10 M10 M11 M
Gross operating profit-4 M5 M18 M19 M17 M20 M14 M20 M22 M18 M
ImpairmentOfCapitalAssets-23000.02 M
Income before tax-14 M-25 M-3 M-21 M-4 M-4 M-4 M-3 M-5 M-11 M
Income restructuring and M&A10 M
Income taxes119000.0255000.0129000.0-264000.0-149000.0275000.034000.063000.0-92000.0
InsuranceAndClaims2 M
Interest income-3 M-20 M-1 M150000.015000.089000.0231000.0
InterestExpenseNonOperating2 M10 M5 M3 M1 M515000.0211000.0314000.0926000.02 M
InterestIncomeOperating4 M2 M
LossAndLossAdjustmentExpectedIncurred3 M
MiscOtherSpecialCharges-6 M2 M5 M-32 M200000.0-414000.0100000.02 M900000.0-909000.0
Net income from total operations-30 M-53 M-3 M-34 M-5 M-4 M-4 M-3 M-6 M-11 M
NetIncomeCommonStockholders-30 M-53 M-3 M-34 M-5 M-4 M-4 M-3 M-6 M-22 M
NetIncomeContinuousOperations-30 M-53 M-3 M-34 M-5 M-4 M-4 M-3 M-6 M-11 M
NetNonOperatingInterestIncomeExpense-6 M-10 M-5 M-3 M-2 M-515000.0-61000.0-299000.0-837000.0-1 M
NetOperatingInterestIncomeExpense-515000.0
Operating income-19 M-19 M-4 M-2 M-3 M-3 M-4 M-4 M-5 M-9 M
Operating income before depreciation (EBITDA)-8 M-2 M11 M-11 M2 M1 M-15000.02 M1 M-3 M
OperatingExpense-13 M-21 M-22 M-21 M-20 M-23 M18 M24 M26 M25 M
Other income net6 M23 M-5 M29 M-200000.0414000.0-100000.0-2 M-900000.0-3 M
OtherGandA8 M10 M8 M8 M9 M10 M8 M10 M10 M11 M
OtherImpairmentOfCapitalAssets-920000.0196000.0194000.0
OtherOperatingExpenses-13 M-21 M-22 M-21 M-20 M-23 M18 M400000.026 M27 M
OtherTaxes9 M
OtherunderPreferredStockDividend-2 M
PreferredStockDividends-2 M
PromotionAndAdvertising-2 M-3 M-1 M-1 M-2 M700000.02 M2 M500000.0
RentAndLandingFees8 M10 M8 M8 M9 M10 M10 M
Research & development expense2 M2 M2 M2 M1 M1 M10 M1 M1 M1 M
ResearchExpense2 M2 M2 M2 M1 M1 M10 M1 M1 M1 M
RestructringAndMnAIncome10 M
Revenue per share2 M-8 M-2 M-3 M-2 M-2 M9 M9 M9 M7 M
SalariesAndWages-413000.0-2 M-113000.0-186000.0-904000.0-1 M2 M2 M1 M
Selling Gen & administrative expense11 M22 M20 M19 M19 M22 M17 M23 M25 M23 M
SellingAndMarketingExpense3 M12 M12 M11 M11 M12 M9 M13 M15 M13 M
SellingExpense3 M9 M12 M11 M11 M12 M13 M
Special income/charges23000.0-10 M-2 M
Total Income available for interest expense (EBIT)-12 M-15 M2 M-18 M-3 M-3 M-4 M-2 M-5 M-9 M
Total common shares outstanding2 M2 M2 M4 M33 M34 M34 M35 M35 M35 M
Total net income-30 M-53 M-3 M-34 M-5 M-4 M-4 M-3 M-6 M-11 M
Total ordinary shares4 M4 M4 M4 M4 M4 M4 M4 M4 M4 M
Total revenues915000.018 M31 M32 M30 M32 M23 M30 M36 M33 M
TotalExpenses-18 M-35 M-34 M-34 M-33 M-35 M27 M49 M41 M40 M
TotalRevenue915000.018 M31 M32 M30 M32 M23 M30 M36 M33 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University